Dr. Bethany A. Reutemann, MD

Dr. Reutemann practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Dr. Reutemann's NPI, 1285070136, was assigned on May 20, 2013. Dr. Reutemann graduated from Jefferson Medical College of Thomas Jefferson University in 2013. Dr. Reutemann holds New Hampshire license 20354.

Dr. Reutemann's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Dr. Reutemann's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dr. Reutemann is also affiliated with Elliot Hospital. The medical group on file is Dartmouth Hitchcock Clinics Manchester. Dmand AI also links Dr. Reutemann to 2 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reutemann practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Reutemann's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Reutemann's licenses on file in 2 states: New Hampshire and Virginia.

CMS data shows 299 Medicare services from Dr. Reutemann across 6 procedure codes in 2024, for 218 Medicare patients. Medicare paid $26,272 for them.

CMS counts 218 Medicare patients who saw Dr. Reutemann in 2024. The largest group is 65 to 74, with 106 patients. 72% of them have high cholesterol, and 64% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Reutemann's median patient age at 56, with 65% women.

In 2024, Dr. Reutemann wrote 609 Medicare Part D claims for 126 patients. 79% of them were for generic drugs. CMS names the drug for 467 of them, across 17 drugs with 11 or more claims each, at $145,907 in total drug cost. In 2023, CMS named 320 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Reutemann for performance year 2024, reported through an alternative payment model (APM). Dr. Reutemann accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reutemann as offering telehealth. CMS counts 77 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Reutemann, more than 71% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Reutemann, published from 2017 to 2022. 2017 was the busiest year, with 2. The most frequent topics are Diagnosis, Differential. Dr. Reutemann's most frequent co-authors are Tristan Wise Feierabend, MD, Andrew R. Reinink, MD and Ryan William Stidham, MD.

CMS Open Payments shows 1 general payment to Dr. Reutemann from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $98.

Dr. Reutemann graduated from Jefferson Medical College of Thomas Jefferson University in 2013.